Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Beta-Lactam Antibiotics InitiaL ExpoSure OptimisEd in CriticallY Ill Patients with SEpsis

NCT06766461 is registered in ClinicalTrials.gov with Erasmus Medical Center as lead sponsor.

NCT NCT06766461
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06766461 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Beta-Lactam Antibiotics InitiaL ExpoSure OptimisEd in CriticallY Ill Patients with SEpsis
Lead sponsor
Erasmus Medical Center
Phase
Phase 4
Overall status
Recruiting
Start date
January 3, 2025
Completion date
December 1, 2027
Enrollment
980 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

sepsis, sepsis - to reduce mortality in the intensive care unit, septic shock